Bafna Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
BAFNAPH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Bafna Pharmaceuticals has informed the stock exchanges that its trading window will be closed starting April 1, 2026, in line with SEBI's insider trading regulations. The window will remain shut until 48 hours after the company declares its audited financial results for the quarter and financial year ending March 31, 2026. During this period, all designated persons and their immediate relatives are prohibited from trading in the company's shares. This is a routine compliance step taken before the announcement of yearly and quarterly results.
This is a standard regulatory filing with no direct impact on shareholders. It signals that the company's audited Q4 and FY26 results are likely to be announced in the coming weeks, which is the key event investors should watch for.